Research Article
Relation of Adiponectin to Glucose Tolerance Status, Adiposity, and Cardiovascular Risk Factor Load
Table 1
Clinical characteristics of study patients by glucose tolerance status.
| | Variables | NGT group
| IFG group
| DM group
|
| | Female/male | 3916 | 717 | 1711 | | Age (y) | | | | | BMI (kg/m²) | | | | | Current smokers, (%) | 7 (13%) | 3 (8%) | 3 (11%) | | Hypertension, (%) | 28 (52%) | 10 (42%) | 15 (54%) | | Dyslipidemia, (%) | 24 (44%) | 12 (50%) | 17 (61%) | | Systolic blood pressure (mmHg) | | | | | Diastolic blood pressure (mmHg) | | | | | Fasting glucose (mg/dL) | |
*
|
*
| | HBAIC (%) | |
*
|
*
| | HDL-cholesterol (mg/dL) | |
*
|
*
| | Triglycerides (mg/dL) | |
*
|
*
| | Hs-CRP (mg/dL) | | | | | ALT (mg/dL) | | |
*
| | AST (mg/dL) | | | | | Fasting insulin (IU/mL) | |
*
|
*
| | HOMA-IR | |
*
|
*
| | Adiponectin (ng/mL) | |
*
|
*
|
|
|
*
value versus NGT group (significant at the 0.05 level).
|
